title: Switching from current factor VIII (FVIII) to longer acting FVIII concentrates--what is the real potential benefit?
authors: Division of Haematology/Oncology, Department of Paediatrics and Research Institute, Hospital for Sick Children, University of Toronto, Toronto, ON, Canada.
authors: M
authors: M
authors: Carcao
mesh_terms: D057915:Drug Substitution; D005169:Factor VIII / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D006207:Half-Life; D006467:Hemophilia A / Q000188:drug therapy*; D006801:Humans; D055118:Medication Adherence; D016896:Treatment Outcome
chemical_list: D005169:Factor VIII